Broad Street Alerts Issues Watch List and Due Diligence Report’s
April 19 2016 - 8:10AM
InvestorsHub NewsWire
NEW YORK, NY – April 18th, 2016 --
Investors Hub NewsWire – http://www.BroadStreetAlerts.com
monitors and scans the markets for stock related signals as well as
any external factors that might bring trading opportunities.
Through a vast network of IR professionals
www.Broadstreetalerts.com is often on the lookout for either large
investor relations campaigns being deployed or stocks gaining
momentum.
To subscribe by phone and receive
messages directly to your mobile phone in real time, text keyword
"Alerts" to 25827.
We believe the following companies could
be getting some attention in the near future follow the links for
the full report.
Skyline Medical Inc. (NASDAQ:
SKLN)
Skyline Medical Inc. has a fully
automated, patented, and FDA cleared surgical fluid disposal
devices - the STREAMWAY System - that virtually eliminates
operating room worker’s exposure to blood, irrigation fluid and
other potentially infectious fluids found in the surgical
environment. Full report- http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
Strikeforce Technologies, Inc. (OTCMKT:
SFOR)
StrikeForce Technologies provides a suite
of online products that help prevent cyber theft and data breaches
by protecting customers, employees and partners in real time at
every vulnerable point. Its products prevent fraud during account
creation, account access, transactions and changes, and transaction
verification, saving businesses millions of dollars, offering new
levels of customer protection, and strengthening their brand
names. Full report-
http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
Northwest Biotherapeutics, Inc. (NASDAQ:
NWBO)
Northwest Biotherapeutics, Inc. is a
development stage biotechnology company focused on discovering,
developing and commercializing immunotherapy products that generate
and enhance immune system responses to treat cancer. The Company
operates in the United States and is incorporated in Delaware, USA.
Full report- http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
Amarin Corp. Plc (NASDAQ:
AMRN)
Amarin Corporation plc, a
biopharmaceutical company, focuses on the development and
commercialization of therapeutics for the treatment of
cardiovascular diseases in the United States. The companys lead
product includes Vascepa, a prescription-only omega-3 fatty acid
capsule, used as an adjunct to diet for reducing triglyceride
levels in adult patients with severe hypertriglyceridemia. It is
also involved in developing Vascepa for the treatment of patients
with high triglyceride levels who are also on statin therapy for
elevated low-density lipoprotein cholesterol levels. The company
was formerly known as Ethical Holdings plc and changed its name to
Amarin Corporation plc in 1999. Amarin Corporation plc was founded
in 1989 and is based in Dublin, Ireland. Full report-
http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
About Broad Street Alerts
We make the connection between
sophisticated investors and high quality micro and small cap
companies. An issuer of reports that provide a straightforward
assessment of the profiled company. They include stocks traded in
the NYSE, NASDAQ, and OTCBB exchanges.
Safe Harbor Statement
This press release may include
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including statements
related to anticipated revenues, expenses, earnings, operating cash
flows, the outlook for markets and the demand for products.
Forward-looking statements are no guarantees of future performance
and are inherently subject to uncertainties and other factors which
could cause actual results to differ materially from the
forward-looking statements. Such statements are based upon, among
other things, assumptions made by, and information currently
available to, management, including management's own knowledge and
assessment of the Company's industry and competition. The Company
refers interested persons to its most recent Annual Report on Form
10-K and its other SEC filings for a description of additional
uncertainties and factors, which may affect forward-looking
statements. The company assumes no duty to update its
forward-looking statements
Compliance
Procedure
Content is researched, written and
reviewed on a best-effort basis by a 3rd party research analyst.
However, we are only human and may make mistakes. This report was
prepared for informational purposes only. A full disclaimer
can be found by viewing the full analyst report. We do not hold any
positions and have not been compensated in any form for this press
release and coinciding reports. For more information and services
provided beyond this press release please use contact information
provided below. If you notice any errors or omissions, please
notify us.
Source: Broad Street Alerts
Contact: editor@broadstreetalerts.com
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Jul 2023 to Jul 2024